The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...

Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella® heart pump technology at the American College of ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for ...

They have been given the name “brain zaps” in online social media communities. These sudden, brief, electric shock sensations in the head are described as lasting for about two to five seconds. They ...